Mental Health Daily

2 Neuroanatomical Subtypes Identified for First-Episode Depression (2024 Study)

by GLOOM

Depression, with its cloak of sadness and despair, affects millions worldwide, presenting a complex puzzle for scientists and clinicians alike. Recent research leveraging machine learning and high-resolution brain imaging has begun to unravel this complexity, revealing two distinct neuroanatomical subtypes of first-episode, treatment-naïve depression. This study offers fresh insights into depression’s heterogeneity, promising more tailored …

How People Feel About Antipsychotics & Mood Stabilizers: Twitter/X Sentiment Analysis (2024 Study)

by GLOOM

Social media has emerged as a pivotal source of real-world evidence, especially in understanding patient experiences and perceptions regarding the treatment of severe mental disorders such as Schizophrenia and related psychotic disorders (SRD) and Bipolar Disorder (BD). Leveraging advanced artificial intelligence (AI) techniques, a comprehensive analysis of 893,289 tweets between 2008 and 2022 revealed significant …

Genetics Predict Suicide Risk in U.S. Army Soldiers (2024 Polygenic Analysis)

by GLOOM

Suicide remains a leading cause of death worldwide, with its prevention a top priority for both public health initiatives and individual care strategies. Recent research in the US Army offers new insights into the genetic underpinnings of suicide attempts, suggesting that polygenic risk scores (PRS) could become a valuable tool in identifying individuals at risk. …

Depression Symptoms & Personality Traits in Older Chinese Adults Over 60 (2024 Study)

by GLOOM

Depression is a multifaceted mental health condition that deeply affects individuals worldwide, particularly the older population. A study in Chinese individuals ages 60 and above sheds light on the complex interplay between depressive symptoms and personality traits, revealing critical insights that could transform how we identify and treat depression in older adults. This research not …

Cannabis-Related Self-Harm & Emergency Room Visits (2010-2021): Increasing Since Legalization

by GLOOM

The legalization and liberalization of cannabis in Canada have sparked debates and concerns regarding its impact on public health, particularly in the context of self-harm behaviors. A comprehensive study in Ontario, Canada, spanning from 2010 to 2021, has revealed significant findings on the relationship between cannabis use and emergency department (ED) visits for self-harm. Highlights: …

Short-Chain Fatty Acids (SCFAs) for Inflammatory Bowel Disease (IBD) (2024 Review)

by GLOOM

Inflammatory Bowel Disease (IBD) represents a group of intestinal disorders that cause prolonged inflammation of the digestive tract, primarily including Crohn’s disease and ulcerative colitis. Recent research has highlighted the vital role of short-chain fatty acids (SCFAs) in mitigating IBD by maintaining intestinal health, regulating immune responses, and supporting the gut microbiome. Traditional Chinese Medicine …

Berberine for Alzheimer’s Disease Treatment: Mechanisms & Efficacy (2023 Review)

by GLOOM

In the quest for more effective treatments for Alzheimer’s Disease (AD), berberine, a bioactive compound derived from traditional Chinese medicine, has emerged as a promising candidate. Recent preclinical studies have showcased its potential to combat the debilitating effects of AD, with evidence pointing towards its ability to improve cognitive functions, reduce hallmark AD pathologies such …